Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HRH4 | SNV | Missense_Mutation | novel | c.517T>C | p.Tyr173His | p.Y173H | Q9H3N8 | protein_coding | deleterious(0.04) | benign(0.316) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
HRH4 | SNV | Missense_Mutation | novel | c.734C>T | p.Pro245Leu | p.P245L | Q9H3N8 | protein_coding | tolerated(0.22) | benign(0.007) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
HRH4 | SNV | Missense_Mutation | novel | c.341T>C | p.Leu114Pro | p.L114P | Q9H3N8 | protein_coding | deleterious(0.01) | probably_damaging(0.971) | TCGA-E6-A2P9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HRH4 | SNV | Missense_Mutation | rs747220498 | c.235N>A | p.Glu79Lys | p.E79K | Q9H3N8 | protein_coding | tolerated(1) | benign(0.01) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
HRH4 | SNV | Missense_Mutation | rs747220498 | c.235G>A | p.Glu79Lys | p.E79K | Q9H3N8 | protein_coding | tolerated(1) | benign(0.01) | TCGA-EO-A3AY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
HRH4 | SNV | Missense_Mutation | novel | c.1058T>C | p.Val353Ala | p.V353A | Q9H3N8 | protein_coding | deleterious(0) | possibly_damaging(0.794) | TCGA-EO-A3AY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
HRH4 | SNV | Missense_Mutation | novel | c.10N>G | p.Thr4Ala | p.T4A | Q9H3N8 | protein_coding | tolerated(0.38) | benign(0) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
HRH4 | SNV | Missense_Mutation | rs751742130 | c.335N>A | p.Arg112Gln | p.R112Q | Q9H3N8 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
HRH4 | insertion | Frame_Shift_Ins | novel | c.611_612insC | p.Asp205Ter | p.D205* | Q9H3N8 | protein_coding | | | TCGA-A5-A0R8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
HRH4 | insertion | In_Frame_Ins | novel | c.612_613insTGTGACACAATG | p.Arg204_Asp205insCysAspThrMet | p.R204_D205insCDTM | Q9H3N8 | protein_coding | | | TCGA-A5-A0R8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | antagonist | 178103918 | MK-0249 | |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135650396 | | |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | antagonist | 135650102 | CIPROXIFAN | |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | antagonist | 310264705 | PITOLISANT | |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | antagonist | CHEMBL3301609 | TOREFORANT | |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135651493 | HISTAMINE | |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | | JNJ-7777120 | JNJ-7777120 | 21920751 |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135650388 | IMPROMIDINE | |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | | risperidone | RISPERIDONE | 23422377 |
59340 | HRH4 | DRUGGABLE GENOME, G PROTEIN COUPLED RECEPTOR | agonist | 135651314 | | |